Alzheimer's disease associated presenilin 1 interacts with HC5 and ZETA, subunits of the catalytic 20S proteasome

Neurobiology of Disease

Volumn 6, Issue 5, 1999, Pages 376-391

  Van Gassen, Geert ^a   De Jonghe, Chris ^a   Pype, Stefan ^a   Van Criekinge, Wim ^a   Julliams, Ann ^a   Vanderhoeven, Inge ^a   Woodrow, Sarah ^a   Beyaert, Rudi ^a   Huylebroeck, Danny ^a   Van Broeckhoven, Christine ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1; PROTEASOME; PROTEINASE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; COMPLEX FORMATION; ENZYME SUBUNIT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

EID: 0032728306     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0265     Document Type: Article

References (55)

1. Alves-Rodrigues A., Gregori L., Figueiredo-Pereira M. E. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends. Neurosci. 21:1998;516-520.
2. Arnold J., Dawson S., Fergusson J., Lowe J., Landon M., Mayer R. J. Ubiquitin and its role in neurodegeneration. Prog. Brain Res. 117:1998;23-34.
3. Baumeister W., Walz J., Zuhl F., Seemuller E. The proteasome: Paradigm of a self-compartmentalizing protease. Cell. 92:1998;367-380.
4. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C. M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Younkin S. G., Sisodia S. S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
5. Capell A., Grunberg J., Pesold B., Diehlmann A., Citron M., Nixon R., Beyreuther K., Selkoe D. J., Haass C. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100- to 150-kDa molecular mass complex. J. Biol. Chem. 273:1998;3205-3211.
6. Coux O., Tanaka K., Goldberg A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
7. Cruts M., Van Broeckhoven C. Molecular genetics of Alzheimer's disease. Ann. Med. 30:1998;560-565.
8. De Jonghe C., Cras P., Vanderstichele H., Cruts M., Vanderhoeven I., Smouts I., Vanmechelen E., Martin J. J., Hendriks L., Van Broeckhoven C. Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype. Neurobiol. Dis. 6:1999a;280-287.
9. De Jonghe C., Cruts M., Rogaeva E. A., Tysoe C., Singleton A., Vanderstichele H., Meschino W., Dermaut B., Vanderhoeven I., Backhovens H., Vanmechelen E., Morris C. M., Hardy J., Rubinsztein D. C., St-George Hyslop P., Van Broeckhoven C. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Aβ42 secretion. Hum. Mol Genet. 8:1999b;1529-1540.
10. De Strooper B., Annaert W., Cupers P., Saftig P., Craessaerts K., Mumm J. S., Schroeter E. H., Schrijvers V., Wolfe M. S., Ray W. J., Goate A., Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain [see Comments]. Nature. 398:1999;518-522.
11. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., St. George Hyslop P., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 272:1997;3590-3598.
12. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein [see Comments]. Nature. 391:1998;387-390.
13. Doan A., Thinakaran G., Borchelt D. R., Slunt H. H., Ratovitsky T., Podlisny M., Selkoe D. J., Seeger M., Gandy S. E., Price D. L., Sisodia S. S. Protein topology of presenilin 1. Neuron. 17:1996;1023-1030.
14. Dumanchin C., Czech C., Campion D., Cuif M. H., Poyot T., Martin C., Charbonnier F., Goud B., Pradier L., Frebourg T. Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport. Hum. Mol. Genet. 8:1999;1263-1269.
15. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
16. Golemis E., Gyuris J., Brent R. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1996;20.1.1-20.1.28 Wiley.
17. Guo Q., Sopher B. L., Furukawa K., Pham D. G., Robinson N., Martin G. M., Mattson M. P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
18. Hendriks L., De Jonghe C., Lubke U., Woodrow S., Vanderhoeven I., Boons J., Cras P., Martin J. J., Van Broeckhoven C. Immunoreactivity of presenilin-1 and tau in Alzheimer's disease brain. Exp. Neurol. 149:1998;341-348.
19. Honda T., Yasutake K., Nihonmatsu N., Mercken M., Takahashi H., Murayama O., Murayama M., Sato K., Omori A., Tsubuki S., Saido T. C., Takashima A. Dual roles of proteasome in the metabolism of presenilin 1. J. Neurochem. 72:1999;255-261.
20. Jensen T. J., Loo M. A., Pind S., Williams D. B., Goldberg A. L., Riordan J. R. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 83:1995;129-135.
21. Kang D. E., Soriano S., Frosch M. P., Collins T., Naruse S., Sisodia S. S., Leibowitz G., Levine F., Koo E. H. Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J. Neurosci. 19:1999;4229-4237.
22. Kim T. W., Pettingell W. H., Hallmark O. G., Moir R. D., Wasco W., Tanzi R. E. Endoproteolytic cleavage and proteasomal degradation of presenilin 2 in transfected cells. J. Biol. Chem. 272:1997;11006-11010.
23. Kopp F., Hendil K. B., Dahlmann B., Kristensen P., Sobek A., Uerkvitz W. Subunit arrangement in the human 20S proteasome. Proc. Natl. Acad. Sci. USA. 94:1997;2939-2944.
24. Kovacs D. M., Fausett H. J., Page K. J., Kim T. W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. G., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., Wasco W. Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2:1996;224-229.
25. Levesque G., Yu G., Nishimura M., Zhang D. M., Levesque L., Yu H., Xu D., Liang Y., Rogaeva E., Ikeda M., Duthie M., Murgolo N., Wang L., VanderVere P., Bayne M. L., Strader C. D., Rommens J. M., Fraser P. E., St. George-Hyslop P. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J. Neurochem. 72:1999;999-1008.
26. Levitan D., Doyle T. G., Brousseau D., Lee M. K., Thinakaran G., Slunt H. H., Sisodia S. S., Greenwald I. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA. 93:1996;14940-14944.
27. Li X., Greenwald I. Membrane topology of the C. elegans SEL-12 presenilin. Neuron. 17:1996;1015-1021.
28. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grunberg J., Haass C., Jacobsen H. Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272:1997;20655-20659.
29. Marambaud P., Ancolio K., Loperez-Perez E., Checler F. Proteasome inhibitors prevent the degradation of familial Alzheimer's disease-linked presenilin 1 and potentiate A beta 42 recovery from human cells. Mol. Med. 4:1998;147-157.
30. Mayer T. U., Braun T., Jentsch S. Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J. 17:1998;3251-3257.
31. Mercken M., Takahashi H., Honda T., Sato K., Murayama M., Nakazato Y., Noguchi K., Imahori K., Takashima A. Characterization of human presenilin 1 using N-terminal specific monoclonal antibodies: Evidence that Alzheimer mutations affect proteolytic processing. FEBS Lett. 389:1996;297-303.
32. Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X., Yasutake K., Nihonmatsu N., Wolozin B., Takashima A. Direct association of presenilin-1 with beta-catenin. FEBS Lett. 433:1998;73-77.
33. Nishimura M., Yu G., Levesque G., Zhang D. M., Ruel L., Chen F., Milman P., Holmes E., Liang Y., Kawarai T., Jo E., Supala A., Rogaeva E., Xu D. M., Janus C., Levesque L., Bi Q., Duthie M., Rozmahel R., Mattila K., Lannfelt L., Westaway D., Mount H. T., Woodgett J., St George-Hyslop P. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex [see Comments]. Nat. Med. 5:1999;164-169.
34. Passer B. J., Pellegrini L., Vito P., Ganjei J. K., D'Adamio L. Interaction of Alzheimer's presenilin-1 and presenilin-2 with bcl-X(L). A potential role in modulating the threshold of cell death. J. Biol. Chem. 274:1999;24007-24013.
35. Pradier L., Carpentier N., Delalonde L., Clavel N., Bock M. D., Buee L., Mercken L., Tocque B., Czech C. Mapping the APP/presenilin (PS) binding domains: The hydrophilic N-terminus of PS2 is sufficient for interaction with APP and can displace APP/PS1 interaction. Neurobiol. Dis. 6:1999;43-55.
36. Prihar G., Gonzalez de Chavez F., Baker M., Crook R., McGowan E., Grover A., Hardy J., Hutton M. A novel candidate presenilin-1 interacting protein containing tetratricopeptide repeats. Neuroreport. 10:1999;1409-1415.
37. Saigoh K., Wang Y.-L., Suh J.-G., Yamanishi T., Sakai Y., Kiyosawa H., Harada T., Ichihara N., Wakana S., Kikuchi T., Wada K. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23:1999;47-51.
38. Schwartz A. L., Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med. 50:1999;57-74.
39. Shen J., Bronson R. T., Chen D. F., Xia W., Selkoe D. J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell. 89:1997;629-639.
40. Steiner H., Capell A., Pesold B., Citron M., Kloetzel P. M., Selkoe D. J., Romig H., Mendla K., Haass C. Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J. Biol. Chem. 273:1998;32322-32331.
41. Tanahashi H., Tabira T. Isolation of human delta-catenin and its binding specificity with presenilin 1. Neuroreport. 10:1999;563-568.
42. Tesco G., Kim T. W., Diehlmann A., Beyreuther K., Tanzi R. E. Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation. J. Biol. Chem. 273:1998;33909-33914.
43. Thinakaran G., Borchelt D. R., Lee M. K., Slunt H. H., Spitzer L., Kim G., Ratovitsky T., Davenport F., Nordstedt C., Seeger M., Hardy J., Levey A. I., Gandy S. E., Jenkins N. A., Copeland N. G., Price D. L., Sisodia S. S. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron. 17:1996;181-190.
44. Thinakaran G., Harris C. L., Ratovitski T., Davenport F., Slunt H. H., Price D. L., Borchelt D. R., Sisodia S. S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272:1997;28415-28422.
45. Thinakaran G., Regard J. B., Bouton C. M., Harris C. L., Price D. L., Borchelt D. R., Sisodia S. S. Stable association of presenilin derivatives and absence of presenilin interactions with APP. Neurobiol. Dis. 4:1998;438-453.
46. Tomita T., Maruyama K., Saido T. C., Kume H., Shinozaki K., Tokuhiro S., Capell A., Walter J., Grunberg J., Haass C., Iwatsubo T., Obata K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA. 94:1997;2025-2030.
47. Van de Craen M., De Jonghe C., van den Brande I., Declercq W., Van Gassen G., Van Criekinge W., Vanderhoeven I., Fiers W., Van Broeckhoven C., Hendriks L., Vandenabeele P. Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett. 445:1999;149-154.
48. Vito P., Wolozin B., Ganjei J. K., Iwasaki K., Lacana E., D'Adamio L. Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J. Biol. Chem. 271:1996;31025-31028.
49. Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T., Selkoe D. J. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 398:1999;513-517.
50. Wolozin B., Iwasaki K., Vito P., Ganjei J. K., Lacana E., Sunderland T., Zhao B., Kusiak J. W., Wasco W., D'Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 274:1996;1710-1713.
51. Wong P. C., Zheng H., Chen H., Becher M. W., Sirinathsinghji D. J., Trumbauer M. E., Chen H. Y., Price D. L., Van der Ploeg L., Sisodia S. S. Presenilin 1 is required for Notch 1 and DII1 expression in the paraxial mesoderm. Nature. 387:1997;288-292.
52. Yu G., Chen F., Levesque G., Nishimura M., Zhang D. M., Levesque L., Rogaeva E., Xu D., Liang Y., Duthie M., St-George-Hyslop P., Fraser P. E. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol. Chem. 273:1998;16470-16475.
53. Zhang W., Han S. W., McKeel D. W., Goate A., Wu J. Y. Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18:1998;914-922.
54. Zhang Z., Hartmann H., Do V. M., Abramowski D., Sturchler-Pierrat C., Staufenbiel M., Sommer B., van de Wetering M., Clevers H., Saftig P., De Strooper B., He X., Yankner B. A. Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature. 395:1998;698-702.
55. Zhou J., Liyanage U., Medina M., Ho C., Simmons A. D., Lovett M., Kosik K. S. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport. 8:1997;2085-2090.